Below is a lightly edited, AI-generated transcript of the “First Opinion Podcast” interview with Sarah Mupo. Be sure to sign up for the weekly “First Opinion Podcast” on Apple Podcasts, Spotify, or wherever you get your podcasts. Get alerts about each new episode by signing up for the “First Opinion Podcast” newsletter. And don’t forget to sign … [Read more…]
You’re reading the web edition of STAT’s ADA in 30 Seconds newsletter from the American Diabetes Association’s annual conference. Sign up here This is Elizabeth Cooney saying hello from New Orleans, where the weather is warm, the conference center is cool, and debates can be fiery. Welcome to the first of three ADA in 30 … [Read more…]
This is the online version of STAT’s weekly email newsletter Health Care Inc. Sign up here. Spring break is here, and our family is road tripping to South Carolina to escape this pretty rough Midwest winter. Send along your favorite snacks, games, playlists, and (of course) health care tips: bob.herman@statnews.com. The Texas couple living large off … [Read more…]
Everyone has those movies they love to watch over and over again. For STATus Report host Alex Hogan, the 1993 thriller “The Fugitive” has been in rotation since he was 8 years old. Recently, Hogan realized the movie’s plot — centered around a pharmaceutical company scandal — is exactly the kind of story STAT would … [Read more…]
Artificial intelligence can detect breast cancer on screening mammograms more accurately than individual expert radiologists in some study settings. In a 2020 Nature study using large U.K. and U.S. datasets, Google Health’s AI system matched or exceeded the performance of six radiologists and, in the U.S. test set, reduced false negatives by 9.4% and false … [Read more…]
A reader — I’ll call him Jack — recently asked my thoughts on his plans to pursue treatment with lecanemab for his mild cognitive impairment caused by Alzheimer’s disease. So we set up a call to discuss what it is like to live beset by the threat of Alzheimer’s disease, but also the promise of … [Read more…]
Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others. That’s right. Send us your changes, and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going. And here is our regular feature in which … [Read more…]
WASHINGTON — The Trump administration announced a draft framework Wednesday that officials say will speed cheaper versions of biologic drugs to market with the aim of making medicine more affordable and accessible for patients. The framework will shorten the path for the Food and Drug Administration to approve biosimilars, or copycat versions of biologic drugs, … [Read more…]
Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others. That’s right. Send us your changes, and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going. Our usual feature — in which we spotlight … [Read more…]
WASHINGTON — Federal officials have approved another generic version of the abortion pill mifepristone, a regulatory formality that quickly triggered pushback from anti-abortion groups and politicians aligned with the Trump administration. Drugmaker Evita Solutions announced on its website that the Food and Drug Administration signed off on its low-cost form of the pill, which is approved to end pregnancies through 10 … [Read more…]